P01-DE12704/DE/NIDCR NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2001	3
2002	2
2003	1
2005	3
2006	1
2022	0

1

Somatic acquisition and signaling of TGFBR1*6A in cancer.

Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, Frankel W, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, Vokes EE, Lane WS, Huang CC, Caldes T, Di Cristofano A, Hampel H, Nilsson I, von Heijne G, Fodde R, Murty VV, de la Chapelle A, Weghorst CM. Pasche B, et al. JAMA. 2005 Oct 5;294(13):1634-46. doi: 10.1001/jama.294.13.1634. JAMA. 2005. PMID: 16204663

2

Chemoprevention of oral cancer by black raspberries.

Casto BC, Kresty LA, Kraly CL, Pearl DK, Knobloch TJ, Schut HA, Stoner GD, Mallery SR, Weghorst CM. Casto BC, et al. Anticancer Res. 2002 Nov-Dec;22(6C):4005-15. Anticancer Res. 2002. PMID: 12553025

3

p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.

Wang D, Grecula JC, Gahbauer RA, Schuller DE, Jatana KR, Biancamano JD, Lang JC. Wang D, et al. Oncol Rep. 2006 Mar;15(3):661-5. Oncol Rep. 2006. PMID: 16465427

4

Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries.

Han C, Ding H, Casto B, Stoner GD, D'Ambrosio SM. Han C, et al. Nutr Cancer. 2005;51(2):207-17. doi: 10.1207/s15327914nc5102_11. Nutr Cancer. 2005. PMID: 15860443

5

Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.

Ding H, Han C, Zhu J, Chen CS, D'Ambrosio SM. Ding H, et al. Int J Cancer. 2005 Feb 20;113(5):803-10. doi: 10.1002/ijc.20639. Int J Cancer. 2005. PMID: 15499625 Free article.

6

Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.

Lang JC, Schuller DE. Lang JC, et al. Br J Cancer. 2001 Jan;84(2):237-43. doi: 10.1054/bjoc.2000.1586. Br J Cancer. 2001. PMID: 11161383 Free PMC article.

7

Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.

Knobloch TJ, Lynch MA, Song H, DeGroff VL, Casto BC, Adams EM, Alam KY, Lang JC, Schuller DE, Weghorst CM. Knobloch TJ, et al. Mutat Res. 2001 Aug 8;479(1-2):131-9. doi: 10.1016/s0027-5107(01)00157-9. Mutat Res. 2001. PMID: 11470488

8

Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF.

Lang JC, Borchers J, Danahey D, Smith S, Stover DG, Agrawal A, Malone JP, Schuller DE, Weghorst CM, Holinga AJ, Lingam K, Patel CR, Esham B. Lang JC, et al. Int J Oncol. 2002 Aug;21(2):401-8. doi: 10.3892/ijo.21.2.401. Int J Oncol. 2002. PMID: 12118338

9

Identification of genetic alterations in the TGFbeta type II receptor gene promoter.

Seijo ER, Song H, Lynch MA, Jennings R, Qong X, Lazaridis E, Muro-Cacho C, Weghorst CM, Muñoz-Antonia T. Seijo ER, et al. Mutat Res. 2001 Nov 1;483(1-2):19-26. doi: 10.1016/s0027-5107(01)00217-2. Mutat Res. 2001. PMID: 11600128

10

Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.

Ding H, Han C, Gibson-D'Ambrosio R, Steele VE, D'Ambrosio SM. Ding H, et al. Int J Cancer. 2003 Dec 10;107(5):830-6. doi: 10.1002/ijc.11499. Int J Cancer. 2003. PMID: 14566835 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results